Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Rutherrin

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Apr 17, 2022 3:49am

152 Views

Post# 34608128

RE:RE:RE:RE:RE:RE:RE:RE:Rutherrin

Never posted off-topic and make no apologies for persisting with this one.

Is it not understood here that in the Fall of 2020 we were given a firm (Q4 2021) intended start for 2 small cheap and quick Phase IB Clinical Trials which through mere proof of principle would have stuck a zero on the dollar share price value of anything that a successful NMIBC Trial will be likely to achieve?

Since then one of these Trials has been dropped and the other kicked so far down the road as to be almost out of sight.

You don`t think that we`re even entitled to be told why???

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle